A systematic review and meta-analysis of the effects of infliximab on the rate of colectomy and post-operative complications in patients with inflammatory bowel disease

Archives of Medical Science

Volumn 7, Issue 6, 2011, Pages 1000-1012

  Ehteshami Afshar, Solmaz ^a,b   Nikfar, Shekoufeh ^c,d   Rezaie, Ali ^e   Abdollahi, Mohammad ^b,c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^e UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anti TNF; Colectomy; Inflammatory bowel disease; Infliximab; Meta analysis; Post operative complications; Systematic review

Indexed keywords

INFLIXIMAB; PLACEBO;

ABDOMINAL ABSCESS; ANASTOMOSIS LEAKAGE; ARTICLE; COLON RESECTION; CROHN DISEASE; DRUG EFFECT; DRUG EFFICACY; DYSPEPSIA; GASTROESOPHAGEAL REFLUX; HOSPITALIZATION; HUMAN; ILEUS; MORTALITY; NAUSEA; OBSERVATIONAL STUDY; PELVIS ABSCESS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; RISK FACTOR; SEPSIS; SMALL INTESTINE OBSTRUCTION; THROMBOSIS; ULCERATIVE COLITIS; VOMITING; WOUND INFECTION;

EID: 84855414971     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: 10.5114/AOMS.2011.26612     Document Type: Article

References (34)

1. Matricon J, Barnich N, Ardid D. Immunopathogenesis of inflammatory bowel disease. Landes Bioscience 2010; Self/Nonself 1:4: 299-309.
2. Rezaie A, Parker RD, Abdollahi M. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig Dis Sci 2007; 52: 2015-21. (Pubitemid 47246507)
3. Nikfar S, Rahimi R, Rezaie A, Abdollahi M. A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis. Dig Dis Sci 2009; 54: 1157-70.
4. Rahimi R, Nikfar S, Rezaie A, Abdollahi M. Comparison of mesalazine and balsalazide in induction and maintenance of remission in patients with ulcerative colitis: a meta-analysis. Dig Dis Sci 2009; 54: 712-21.
5. Rahimi R, Nikfar S, Abdollahi M. Meta-analysis technique confirms the effectiveness of anti-TNF in the management of active ulcerative colitis when administered in combination with corticosteroids. Med Sci Monit 2007; 13: PI13-18. (Pubitemid 47037680)
6. Nikfar S, Ehteshami-Afshar S, Abdollahi M. A systematic review and meta-analysis of the efficacy and adverse events of Infliximab in comparison to corticosteroids and placebo in active ulcerative colitis. Int J Pharmacol 2011; 7: 325-32.
7. Rahimi R, Nikfar S, Abdollahi M. Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials. Biomed Pharmacother 2007; 61: 75-80. (Pubitemid 46185874)
8. Hancock L, Mortensen NJ. How often do IBD patients require resection of their intestine? Inflamm Bowel Dis 2008; 14 (Suppl 2): S68-9.
9. Ferrante M, D'Hoore A, Vermeire S, et al. Corticosteroids but not infliximab increase short-term postoperative infectious complications in patients with ulcerative colitis. Inflamm Bowel Dis 2009; 15: 1062-70.
10. Kunitake H, Hodin R, Shellito PC, et al. Perioperative treatment with infliximab in patients with Crohn's disease and ulcerative colitis is not associated with an increased rate of postoperative complications. J Gastrointest Surg 2008; 12: 1730-6.
11. Bordeianou L, Kunitake H, Shellito P, Hodin R. Preoperative infliximab treatment in patients with ulcerative and indeterminate colitis does not increase rate of conversion to emergent and multistep abdominal surgery. Int J Colorectal Dis 2010; 25: 401-4.
12. Sandborn WJ, Rutgeerts P, Feagan BG, et al. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology 2009; 137: 1250-60.
13. Yang Z, Wu Q, Wu K, Fan D. Meta-analysis: pre-operative infliximab treatment and short-term post-operative complications in patients with ulcerative colitis. Aliment Pharmacol Ther 2010; 31: 486-92.
14. Jadad AR, Enkin MW. Randomised controlled trials. 2nd ed. London, United Kingdom: BMJ Books 2007.
15. Gustavsson A, Järnerot G, Hertervig E, et al. Clinical trial: colectomy after rescue therapy in ulcerative colitis - 3-year follow-up of the Swedish-Danish controlled infliximab study. Aliment Pharmacol Ther 2010; 32: 984-9.
16. Järnerot G, Hertervig E, Friis-Liby I, et al. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study. Gastroenterology 2005; 128: 1805-11. (Pubitemid 40824691)
17. Marchal L, D'Haens G, Van Assche G, et al. The risk of postoperative complications associated with infliximab therapy for Crohn's disease: a controlled cohort study. Aliment Pharmacol Ther 2004; 19: 749-54.
18. Schluender SJ, Ippoliti A, Dubinsky M, et al. Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis? Dis Colon Rectum 2007; 50: 1747-53. (Pubitemid 350077092)
19. Colombel JF, Loftus EV Jr, Tremaine WJ, et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 2004; 99: 878-83. (Pubitemid 39090217)
20. Appau KA, Fazio VW, Shen B, et al. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients. J Gastrointest Surg 2008; 12: 1738-44.
21. Selvasekar CR, Cima RR, Larson DW, et al. Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 2007; 204: 956-62. (Pubitemid 46661200)
22. Mor IJ, Vogel JD, da Luz Moreira A, et al. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative procto-colectomy. Dis Colon Rectum 2008; 51: 1202-7.
23. Wilhelm SM, McKenney KA, Rivait KN, Kale-Pradhan PB. A review of infliximab use in ulcerative colitis. Clin Ther 2008; 30: 223-30. (Pubitemid 351474384)
24. Bressler B, Law JK, Al-Nahdi-Sheraisher N, et al. The use of infliximab for treatment of hospitalized patients with acute severe ulcerative colitis. Can J Gastroenterol 2008; 22: 937-40.
25. Aratari A, Papi C, Clemente V, et al. Colectomy rate in acute severe ulcerative colitis in the infliximab era. Dig Liver Dis 2008; 40: 821-6.
26. Kohn A, Daperno M, Armuzzi A, et al. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment Pharmacol Ther 2007; 26: 747-56. (Pubitemid 47246204)
27. Lees CW, Heys D, Ho GT, et al. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis. Aliment Pharmacol Ther 2007; 26: 411-9. (Pubitemid 47063146)
28. Shen B. Impact of preoperative infliximab use on postoperative infectious complications in ulcerative colitis: the price we have to pay? Inflamm Bowel Dis 2008; 14: 1019-21.
29. Mshale MJ, Seow CH, Coffin CS, et al. Review article: chronic viral infection in the anti-tumour necrosis factor therapy era in inflammatory bowel disease. Aliment Pharmacol Ther 2010; 31: 20-34.
30. Nikfar S, Mirfazaelian H, Abdollahi M. Efficacy and tolerability of immunoregulators and antibiotics in fistulizing Crohn's disease: a systematic review and meta-analysis of placebo-controlled trials. Curr Pharm Des 2010; 16: 3684-98.
31. Nikfar S, Darvish-Damavandi M, Abdollahi M. A review and meta-analysis of the efficacy of antibiotics and probiotics in management of pouchitis. Int J Pharmacol 2010; 6: 826-35.
32. Rezaie A, Nikfar S, Abdollahi M. The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis. Arch Med Sci 2010; 6: 49-55.
33. Lisowska B, Maśliński W, Małdyk P. Perioperative inflammatory response in patients with rheumatoid arthritis undergoing orthopaedic surgery. Arch Med Sci 2009; 5: 248-54.
34. Egger M, Smith GD, Altman DG. Systematic reviews in health care: meta-analysis in context. 2nd ed. London, United Kingdom, BMJ Books 2001.